Freestone Capital Holdings, LLC Novartis Ag Transaction History

Freestone Capital Holdings, LLC

  • $2.9 Billion
  • Q3 2024

A detailed history of Freestone Capital Holdings, LLC transactions in Novartis Ag stock. As of the latest transaction made, Freestone Capital Holdings, LLC holds 3,960 shares of NVS stock, worth $409,543. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,960
Previous 4,040 1.98%
Holding current value
$409,543
Previous $430,000 5.81%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$106.13 - $120.89 $8,490 - $9,671
-80 Reduced 1.98%
3,960 $455,000
Q2 2024

Aug 13, 2024
SELL
$92.57 - $107.37 $32,214 - $37,364
-348 Reduced 7.93%
4,040 $430,000
Q1 2024

May 14, 2024
SELL
$95.27 - $108.47 $15,338 - $17,463
-161 Reduced 3.54%
4,388 $424,000
Q4 2023

Feb 13, 2024
SELL
$92.27 - $101.54 $17,531 - $19,292
-190 Reduced 4.01%
4,549 $459,000
Q3 2023

Nov 14, 2023
SELL
$94.73 - $105.13 $241,182 - $267,660
-2,546 Reduced 34.95%
4,739 $482,000
Q2 2023

Aug 09, 2023
SELL
$92.52 - $104.91 $162,557 - $184,326
-1,757 Reduced 19.43%
7,285 $735,000
Q1 2023

May 12, 2023
SELL
$80.03 - $92.81 $44,816 - $51,973
-560 Reduced 5.83%
9,042 $831,000
Q4 2022

Feb 13, 2023
SELL
$75.55 - $92.52 $866,558 - $1.06 Million
-11,470 Reduced 54.43%
9,602 $871,000
Q3 2022

Nov 09, 2022
SELL
$74.61 - $87.26 $1.17 Million - $1.37 Million
-15,655 Reduced 42.63%
21,072 $1.6 Million
Q2 2022

Aug 09, 2022
SELL
$80.52 - $93.75 $3.72 Million - $4.33 Million
-46,229 Reduced 55.73%
36,727 $3.11 Million
Q1 2022

May 12, 2022
BUY
$80.11 - $90.62 $867,911 - $981,777
10,834 Added 15.02%
82,956 $7.28 Million
Q4 2021

Feb 14, 2022
SELL
$79.7 - $88.13 $13,549 - $14,982
-170 Reduced 0.24%
72,122 $6.31 Million
Q3 2021

Nov 15, 2021
SELL
$81.78 - $95.14 $632,895 - $736,288
-7,739 Reduced 9.67%
72,292 $5.91 Million
Q2 2021

Aug 16, 2021
SELL
$85.24 - $94.15 $217,191 - $239,894
-2,548 Reduced 3.09%
80,031 $7.3 Million
Q1 2021

May 17, 2021
BUY
$83.5 - $98.47 $2.08 Million - $2.46 Million
24,947 Added 43.29%
82,579 $7.06 Million
Q4 2020

Feb 16, 2021
SELL
$78.07 - $94.43 $1.1 Million - $1.33 Million
-14,034 Reduced 19.58%
57,632 $5.44 Billion
Q3 2020

Nov 06, 2020
SELL
$82.14 - $91.0 $108,342 - $120,029
-1,319 Reduced 1.81%
71,666 $6.23 Million
Q2 2020

Aug 04, 2020
BUY
$80.93 - $91.1 $391,782 - $441,015
4,841 Added 7.1%
72,985 $6.38 Million
Q1 2020

May 12, 2020
BUY
$70.67 - $99.01 $1.83 Million - $2.57 Million
25,941 Added 61.47%
68,144 $5.62 Million
Q4 2019

Feb 04, 2020
BUY
$84.35 - $95.37 $382,949 - $432,979
4,540 Added 12.05%
42,203 $4 Million
Q3 2019

Nov 07, 2019
BUY
$85.54 - $94.26 $140,285 - $154,586
1,640 Added 4.55%
37,663 $3.27 Million
Q2 2019

Aug 05, 2019
BUY
$75.4 - $92.8 $505,481 - $622,131
6,704 Added 22.87%
36,023 $3.29 Million
Q1 2019

May 08, 2019
BUY
$75.32 - $86.15 $388,952 - $444,878
5,164 Added 21.38%
29,319 $2.82 Million
Q4 2018

Feb 12, 2019
BUY
$73.66 - $82.02 $541,474 - $602,929
7,351 Added 43.75%
24,155 $2.07 Million
Q3 2018

Nov 13, 2018
BUY
$66.94 - $77.43 $165,341 - $191,252
2,470 Added 17.23%
16,804 $1.45 Million
Q2 2018

Aug 14, 2018
BUY
$64.91 - $73.36 $127,223 - $143,785
1,960 Added 15.84%
14,334 $1.08 Million
Q1 2018

May 15, 2018
BUY
$70.39 - $84.15 $17,667 - $21,121
251 Added 2.07%
12,374 $1 Million
Q4 2017

Feb 13, 2018
BUY
$72.33 - $77.64 $69,726 - $74,844
964 Added 8.64%
12,123 $1.02 Million
Q3 2017

Nov 14, 2017
BUY
$74.14 - $77.27 $40,109 - $41,803
541 Added 5.1%
11,159 $958,000
Q2 2017

Aug 15, 2017
BUY
N/A
10,618
10,618 $886,000

Others Institutions Holding NVS

# of Institutions
1,431
Shares Held
134M
Call Options Held
1.1M
Put Options Held
1.71M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $222B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Freestone Capital Holdings, LLC Portfolio

Follow Freestone Capital Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Freestone Capital Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Freestone Capital Holdings, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email